Non-Apnoeic Snorers
Conditions
Brief summary
This study will aim to assess the acceptance of the Snore PAP system as a treatment concept for snore. The study will subjectively assess participant and bed partner acceptability and usability of the Snore PAP system and objectively assess participant compliance with the Snore PAP system.
Interventions
DEVICESnore PAP System
The Snore PAP system delivers a set Continuous Positive Airway Pressure (CPAP) and consists of a CPAP flow generator and an approved pillows mask.The system will deliver a fixed positive airflow to the participant via approved tubing and pillows mask.
Sponsors
Eden Sleep
ResMed
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes
Inclusion criteria
* Participants willing to provide written informed consent * Participants who can read and comprehend written and spoken English * Participants who are ≥ 18 years of age * Participants are CPAP naïve * Participants who are self/ partner reported snorers * Participants whose ApneaLink study results demonstrate snore * Participants who are willing to use Nice system in place of current non prescribed methods for alleviating snore * Participants have a bed partner * Participant's bed partner willing to answer assessment questionnaire
Exclusion criteria
* Participants previously diagnosed with obstructive or central sleep apnoea * Participants whose ApneaLink home study indicates AHI ≥6 * Participants who are pregnant or breastfeeding * Participants who have a pre-existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\< 2years) case of pneumonia or lung infection; lung injury) * Participants with severe bullous lung disease, history of pneumothorax, pathologically low blood pressure, dehydration, cerebrospinal fluid leak, recent cranial surgery or trauma. * Participants who cannot participate for the duration of the trial * Participants who are established on bi-level support therapy * Participants currently using a prescribed medication/ device to alleviate snore * Participants who are physically unable to comply with the protocol- no access to internet to conduct online visits with researcher or unable to attend clinic for visit
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Subjectively assess the participant and bed partner acceptability and usability of Snore PAP system | 28 Nights | Subjective assessment will be assessed using the Likert scale using a 0-10 scale. With 0 being very negative and 10 being very positive. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Subjectively assess the performance of the Snore PAP system in relieving: self-reported and bed partner reported snore in non-apnoeic participants. | 28 Nights | Subjective assessment will be assessed using the Likert scale using a 0-10 scale. With 0 being very negative and 10 being very positive. |
| Objectively assess participant compliance with the Snore PAP system | 28 Nights | Hours used per night |
Countries
New Zealand
Outcome results
None listed